Skip to content
Home/Companies/Biotech/Prosion
PR

Prosion

Biotech·Germany·Active·4yr hold

Prosion is a biotech company, headquartered in Germany.

Entry
2022
Hold
4yr
Status
Active
Est. EV
–

Who owns Prosion?

Prosion is currently owned by Freigeist Capital through Freigeist Deep-Tech Evergreen (2017 vintage), since 2022.

Hand-verified · updated 2026-07-03

Freigeist Capital
Investor
Freigeist Capital
Freigeist Deep-Tech Evergreen · 2017 · Evergreen

Key facts

HQGermany
SectorBiotech
StatusActive

More from Freigeist Deep-Tech Evergreen

Other portfolio companies in the same fund.

Akina
Active
MedTechSwitzerland· 2025
Collie
Active
SoftwareGermany· 2025
BioThrust
Active
BiotechGermany· 2024
United Manufacturing Hub
Active
SoftwareGermany· 2024
LEKO LABS
Active
IndustrialsLuxembourg· 2022
BUILD.ONE
Active
SoftwareGermany· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings